Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FLGE
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
|
+$499M |
| 2 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$479M |
| 3 |
Merck
MRK
|
+$328M |
| 4 |
BAY
BAYER AG SPONS ADR
BAY
|
+$287M |
| 5 |
Lloyds Banking Group
LYG
|
+$275M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$958M |
| 2 |
IBM
IBM
|
+$565M |
| 3 |
McDonald's
MCD
|
+$502M |
| 4 |
CSE
CAPITALSOURCE INC
CSE
|
+$95.8M |
| 5 |
PL
PROTECTIVE LIFE CORP
PL
|
+$66.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.81% |
| 2 | Healthcare | 13.89% |
| 3 | Technology | 12.13% |
| 4 | Industrials | 7.64% |
| 5 | Consumer Discretionary | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Shinhan Financial Group
SHG
$34B
| $1.02M | ﹤0.01% |
22,319
+6,030
| +37% | +$269K |
|
352
Vanguard S&P 500 ETF
VOO
$972B
| $954K | ﹤0.01% |
5,317
-3,268
| -38% | -$569K |
|
353
Caterpillar
CAT
$373B
| $890K | ﹤0.01% |
8,186
-4,436
| -35% | -$466K |
|
354
iShares TIPS Bond ETF
TIP
$14.5B
| $872K | ﹤0.01% |
7,555
-1,606
| -18% | -$183K |
|
355
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
| $826K | ﹤0.01% |
10,278
+1,814
| +21% | +$146K |
|
356
Insulet
PODD
$11.5B
| $749K | ﹤0.01% |
+18,888
| New | +$726K |
|
357
Cheniere Energy
LNG
$54.1B
| $746K | ﹤0.01% |
+10,400
| New | +$632K |
|
358
Abbott
ABT
$183B
| $737K | ﹤0.01% |
18,027
+9,281
| +106% | +$364K |
|
359
Incyte
INCY
$24.9B
| $690K | ﹤0.01% |
+12,225
| New | +$624K |
|
360
Under Armour
UAA
$2.91B
| $667K | ﹤0.01% |
+22,589
| New | +$589K |
|
361
PPG Industries
PPG
$24.9B
| $665K | ﹤0.01% |
6,332
-516
| -8% | -$51.2K |
|
362
Colgate-Palmolive
CL
$73.3B
| $663K | ﹤0.01% |
9,718
+714
| +8% | +$47.9K |
|
363
Phillips 66
PSX
$84.4B
| $661K | ﹤0.01% |
8,218
-463
| -5% | -$38.1K |
|
364
British American Tobacco
BTI
$133B
| $654K | ﹤0.01% |
10,988
-4,192
| -28% | -$246K |
|
365
Vertex Pharmaceuticals
VRTX
$122B
| $639K | ﹤0.01% |
+6,753
| New | +$474K |
|
366
Starbucks
SBUX
$121B
| $615K | ﹤0.01% |
15,904
-2,874
| -15% | -$104K |
|
367
Rogers Communications
RCI
$18.4B
| $604K | ﹤0.01% |
15,005
| – | – |
|
368
Lockheed Martin
LMT
$132B
| $593K | ﹤0.01% |
3,690
+106
| +3% | +$17.2K |
|
369
General Mills
GIS
$19.4B
| $585K | ﹤0.01% |
11,126
+6,222
| +127% | +$332K |
|
370
Blackrock
BLK
$170B
| $574K | ﹤0.01% |
+1,797
| New | +$551K |
|
371
Dover
DOV
$27.5B
| $573K | ﹤0.01% |
7,806
-1,188
| -13% | -$83K |
|
372
Rio Tinto
RIO
$158B
| $571K | ﹤0.01% |
10,525
-4,330
| -29% | -$235K |
|
373
iShares Global Healthcare ETF
IXJ
$4.11B
| $561K | ﹤0.01% |
11,900
| – | – |
|
|
CAM
374
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $509K | ﹤0.01% |
7,514
| – | – |
|
|
MHFI
375
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $508K | ﹤0.01% |
+6,124
| New | +$483K |
|
Similar funds
Ken Fisher's Q2 2014 Portfolio in Review
As of Q2 2014, Ken Fisher held 668 positions worth $47.6B, up 7.3% from $44.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher deployed $2.03B of net new capital in Q2 2014, opening 82 new positions and adding to 273 existing holdings. Its largest new stake was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, an estimated $958M trimmed.
- Ken Fisher's largest Q2 2014 buy was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
- Ken Fisher added most to Merck in Q2 2014, an estimated $328M increase.
- Ken Fisher's biggest Q2 2014 reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, cutting an estimated $958M.
- Ken Fisher fully exited CAPITALSOURCE INC in Q2 2014, selling an estimated $95.8M.
- Ken Fisher's ten largest holdings make up 23% of its $47.6B portfolio in Q2 2014.
- Ken Fisher opened 82 new positions and closed 70 in Q2 2014.
- Ken Fisher's portfolio value rose 7.3% quarter-over-quarter to $47.6B.
Based on Fisher Asset Management's 13F filing for Q2 2014, filed 25 Jul 2014.